Prevention of Diabetes-Associated Cognitive Dysfunction Through Oral Administration of Lipopolysaccharide Derived From
Administration, Oral
Animals
Brain
/ drug effects
Cells, Cultured
Cognitive Dysfunction
/ diagnosis
Diabetes Complications
/ drug therapy
Diabetes Mellitus, Experimental
Disease Models, Animal
Lipopolysaccharides
/ administration & dosage
Male
Mice
Microglia
/ drug effects
Neuroprotective Agents
/ administration & dosage
Pantoea
/ chemistry
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor
/ metabolism
Signal Transduction
cognitive dysfunction
dementia
lipopolysaccharide
microglia
neuroprotection
oral administration
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2021
2021
Historique:
received:
06
01
2021
accepted:
13
08
2021
entrez:
13
9
2021
pubmed:
14
9
2021
medline:
29
9
2021
Statut:
epublish
Résumé
Diabetes-related cognitive dysfunction (DRCD) is a serious complication induced by diabetes. However, there are currently no specific remedies for DRCD. Here, we show that streptozotocin-induced DRCD can be prevented without causing side effects through oral administration of lipopolysaccharide (LPS) derived from
Identifiants
pubmed: 34512619
doi: 10.3389/fimmu.2021.650176
pmc: PMC8429836
doi:
Substances chimiques
Csf1r protein, mouse
0
Lipopolysaccharides
0
Neuroprotective Agents
0
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
650176Informations de copyright
Copyright © 2021 Mizobuchi, Yamamoto, Yamashita, Nakata, Inagawa, Kohchi and Soma.
Déclaration de conflit d'intérêts
HM, KY, MY, HI, and G-IS are employed by the Control of Innate Immunity, Collaborative Innovation Partnership. YN, HI, CK, and G-IS are employed by Macrophi Inc. This does not affect our adherence to journal policies on sharing data and materials.
Références
Nat Rev Immunol. 2010 Mar;10(3):170-81
pubmed: 20154735
Anticancer Res. 2009 Mar;29(3):859-64
pubmed: 19414320
Mol Cell. 2020 Jul 2;79(1):43-53.e4
pubmed: 32464093
J Immunol. 2010 Jun 15;184(12):7207-18
pubmed: 20483760
J Immunol. 2005 Nov 1;175(9):5885-94
pubmed: 16237081
J Neural Transm Suppl. 2007;(72):217-33
pubmed: 17982898
Nat Neurosci. 2016 Jan;19(1):94-101
pubmed: 26642091
Brain Behav Immun. 2016 Jul;55:260-272
pubmed: 27132056
Acta Neuropathol Commun. 2020 May 19;8(1):72
pubmed: 32430064
Glia. 2008 Jan 1;56(1):69-77
pubmed: 17932942
J Exp Med. 2013 Jan 14;210(1):157-72
pubmed: 23296467
Front Cell Neurosci. 2018 Jul 03;12:178
pubmed: 30018535
Neurobiol Dis. 2020 Aug;142:104956
pubmed: 32479996
Anticancer Res. 2016 Jul;36(7):3599-605
pubmed: 27354629
Anticancer Res. 2015 Aug;35(8):4467-72
pubmed: 26168488
Nutr Res Pract. 2011 Oct;5(5):435-42
pubmed: 22125681
J Neuroimmune Pharmacol. 2017 Jun;12(2):292-304
pubmed: 27734267
Nat Rev Endocrinol. 2018 Oct;14(10):591-604
pubmed: 30022099
Neuron. 2014 Apr 16;82(2):380-97
pubmed: 24742461
Mol Ther. 2020 Jan 8;28(1):129-141
pubmed: 31677955
Nature. 2018 Apr;556(7701):332-338
pubmed: 29643512
Brain. 2009 Apr;132(Pt 4):1078-92
pubmed: 19151372
Oncotarget. 2016 Jan 12;7(2):1354-66
pubmed: 26595525
Anticancer Res. 2007 Nov-Dec;27(6A):3701-6
pubmed: 17970031
J Neurosci. 2014 Apr 23;34(17):5882-94
pubmed: 24760848
Food Sci Nutr. 2014 Nov;2(6):638-46
pubmed: 25493180
J Neuroinflammation. 2017 Dec 04;14(1):236
pubmed: 29202771
Cell Physiol Biochem. 2009;24(3-4):141-52
pubmed: 19710528
Anticancer Res. 2011 Jul;31(7):2467-76
pubmed: 21873161
Cancer Biol Ther. 2014 Jan;15(1):99-107
pubmed: 24100343
Biotechniques. 2003 Feb;34(2):374-8
pubmed: 12613259
Nat Commun. 2019 Aug 21;10(1):3758
pubmed: 31434879
Neural Regen Res. 2021 Oct;16(10):1928-1934
pubmed: 33642362
PLoS One. 2018 Jun 1;13(6):e0198493
pubmed: 29856882
J Neuroinflammation. 2014 Jul 28;11:132
pubmed: 25065370
J Exp Med. 2019 Nov 4;216(11):2546-2561
pubmed: 31601677
In Vivo. 2016 May-Jun;30(3):205-11
pubmed: 27107076
J Appl Microbiol. 2002;92(2):247-55
pubmed: 11849352
J Appl Toxicol. 2020 Oct;40(10):1342-1352
pubmed: 32346895
FASEB J. 2015 Jun;29(6):2545-54
pubmed: 25757564
Sci Rep. 2019 Apr 8;9(1):5790
pubmed: 30962497
Neural Regen Res. 2015 Jul;10(7):1050-2
pubmed: 26330820
Methods Enzymol. 2006;411:134-93
pubmed: 16939790
Blood. 2012 Oct 11;120(15):3152-62
pubmed: 22919031
J Neurosci. 2005 Apr 27;25(17):4442-51
pubmed: 15858070
PLoS One. 2020 Apr 2;15(4):e0230427
pubmed: 32240179
J Biol Chem. 2001 May 25;276(21):18519-28
pubmed: 11279072
J Cell Sci. 2011 Jun 15;124(Pt 12):2021-31
pubmed: 21610095
J Cancer Res Clin Oncol. 2001 Dec;127(12):727-32
pubmed: 11768612
Food Sci Nutr. 2017 Nov 20;6(1):197-206
pubmed: 29387379
J Neurosci Methods. 2010 Mar 30;187(2):243-53
pubmed: 20097228
Neuroinformatics. 2016 Oct;14(4):479-81
pubmed: 27166960
FASEB J. 2002 Apr;16(6):601-3
pubmed: 11919167
Eur J Immunol. 2009 Jul;39(7):1902-13
pubmed: 19585511
Int Immunopharmacol. 2008 Oct;8(10):1354-76
pubmed: 18687298
N Engl J Med. 2002 Sep 19;347(12):869-77
pubmed: 12239255
Nat Genet. 2002 Dec;32 Suppl:496-501
pubmed: 12454644
Cell. 2014 Jul 17;158(2):300-313
pubmed: 25036630
PLoS One. 2018 Mar 27;13(3):e0195008
pubmed: 29584779
Nat Rev Immunol. 2013 Mar;13(3):206-18
pubmed: 23435332
J Neuropathol Exp Neurol. 2018 Mar 1;77(3):199-206
pubmed: 29319809
Anticancer Res. 2011 Jul;31(7):2431-6
pubmed: 21873155
Sci Transl Med. 2020 Jan 15;12(526):
pubmed: 31941827
Brain. 2008 Jun;131(Pt 6):1416-32
pubmed: 18234698
Anticancer Res. 2016 Jul;36(7):3693-8
pubmed: 27354642
Toxicology. 2004 May 3;197(3):213-28
pubmed: 15033544
Immunology. 1999 Jun;97(2):226-31
pubmed: 10447736